Everything below concerns reversed-phase HPLC. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-03-01. Numbers and descriptions here follow the published literature rather than marketing material.
After subcutaneous administration, plasma concentrations rise within roughly thirty minutes and the elimination half-life is short, on the order of two to three hours. Reported physiological responses include transient increases in blood pressure and nausea, which tended to diminish with repeated dosing in trial settings. Because the peptide clears quickly, effects are not expected to persist long after a dose. Absorption from non-injected routes is poorly characterised, and nasal delivery produced variable plasma levels in older work.
Clinical research typically uses randomised, double-blind, placebo-controlled designs. The most common primary endpoint is the desire domain score of the Female Sexual Function Index, sometimes paired with a distress measure. Secondary outcomes include arousal, satisfaction, and event-based counts of satisfying sexual episodes. Across trials, average improvements are modest and individual responses vary widely. Whether benefits persist beyond a few months, and whether they depend on baseline hormone status, remain open questions rather than settled findings.
Melanocortin receptors form a family of five G-protein-coupled receptors designated MC1 through MC5. Bremelanotide binds most strongly at MC4R and MC1R, with weaker activity reported at MC3R and MC5R. MC4R is expressed in hypothalamic nuclei that coordinate energy balance and aspects of sexual behaviour. The prevailing interpretation is that central MC4R activation, rather than peripheral vascular effects alone, drives the reported changes in desire. This account remains partly inferential, since direct receptor-level measurement in living humans is not practical.
Approved use is narrow and jurisdiction-specific. In the United States, the injectable product is authorised for premenopausal women with acquired, generalised hypoactive sexual desire disorder, a diagnosis that requires documented distress. It is not approved for men, for postmenopausal women, or for use alongside hormonal contraceptives under the approved labelling. Outside regulated markets, the same peptide is frequently sold as a research chemical, where identity, purity, and sterility are not independently verified.
Bremelanotide is a synthetic cyclic heptapeptide developed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and appetite signalling. Its structure contains seven amino acid residues joined by a lactam bridge that closes the ring between two side chains. The molecular formula is C50H68N14O10 and the nominal molecular mass is near 1025 daltons. Much of the early laboratory literature refers to the same molecule by the development code PT-141.
| Property | Value | Notes |
|---|---|---|
| Primary receptor targets | MC4R and MC1R | Agonist activity; MC3R and MC5R weaker |
| Route studied in trials | Subcutaneous injection | Intranasal form was not approved |
| Elimination half-life | Approximately 2–3 hours | Short relative to the dosing interval |
| Common analytical method | Liquid chromatography–tandem mass spectrometry | Used for peptide quantification in plasma |
| Reported adverse events | Nausea, flushing, headache | Transient blood pressure rise also noted |
Identity and purity are usually established with reversed-phase high-performance liquid chromatography combined with mass spectrometry. A gradient of water and acetonitrile containing trifluoroacetic acid is a common mobile phase, and ultraviolet detection near 214 nanometres responds to the peptide backbone. Mass spectrometry confirms the expected molecular mass and helps reveal truncation or oxidation products. Purity is reported as a peak-area percentage, a figure that depends on the wavelength and gradient used, so values from different laboratories are not always directly comparable. Peptide mapping and amino acid analysis provide additional confirmation when required.
Regulatory status varies by jurisdiction, where approved prescription products, compounded preparations and research-grade material are treated as distinct categories with different documentation requirements. Suppliers of research material commonly issue a certificate of analysis listing purity, identity and sometimes endotoxin content. Independent verification by a third-party laboratory is often recommended because self-reported figures are difficult to check. Literature discussions usually state the source, purity and storage conditions of the material used, since these details affect reproducibility. Analysts note that a reported purity figure does not by itself describe biological activity.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Reported pharmacodynamic effects include transient rises in blood pressure and heart rate, flushing, nausea and headache, appearing soon after dosing and resolving within hours. These responses were dose-related in early studies and shaped the label's cardiovascular cautions and blood pressure monitoring advice. Gastrointestinal upset is the most frequent reason cited for discontinuation in trials. Whether the vascular signal attenuates with repeated use is not settled. Central effects on desire are described as emerging over weeks rather than immediately, which points to a cumulative rather than acute process.
The compound binds several melanocortin receptor subtypes rather than a single target, with the strongest functional activity reported at MC4R and measurable activity at MC1R, MC3R and MC5R. MC4R populations are dense in hypothalamic nuclei that integrate energy balance, autonomic tone and reproductive behaviour, which is the anatomical basis for the proposed pro-desire effect. Because binding is not subtype-selective, pigmentary and vascular effects accompany central activity. Improving subtype selectivity is an active area of analogue design. Direct causal mapping from receptor occupancy to reported desire change in humans is not fully established.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
Numerous social media users, including Americans, expressed their opposition to US foreign policy by sharing the resurfaced copies of the letter and its contents. The Guardian website removed the letter after displaying it for more than 20 years, and TikTok began issuing takedowns of videos featuring the letter. Reporting in The Washington Post suggested that the virality of the letter had been limited prior to media coverage, having never trended on TikTok. Many of the TikTok videos covering the letter were critical of bin Laden, and media coverage had exaggerated its significance while elevating the virality of the letter. In July 2025, TikTok hired Erica Mindel, a former Israel Defense Forces instructor and contractor for the US State Department's Special Envoy to Monitor and Combat Antisemitism, as its Public Policy Manager of Hate Speech. Starting in 2026, TikTok began cracking down on the accounts of Palestinian activists and journalists, including Bisan Owda, who had reported on the human rights abuses taking place in Gaza. Media outlets such as Al Jazeera verified that TikTok's new algorithm hid content depending on the user's region, with the app hiding Palestinian content from users in the Middle East.
=== Category:EC 1.17 (act on CH or CH2 groups) === Category:EC 1.17.1 Leucoanthocyanidin reductase EC 1.17.1.3 Xanthine dehydrogenase EC 1.17.1.4 Nicotinate dehydrogenase EC 1.17.1.5 4-hydroxy-tetrahydrodipicolinate reductase EC 1.17.1.8 Category:EC 1.17.2 Nicotinate dehydrogenase (cytochrome) EC 1.17.2.1 Category:EC 1.17.3 Xanthine oxidase EC 1.17.3.2 Category:EC 1.17.4 Ribonucleotide reductase EC 1.17.4.1 Ribonucleoside-triphosphate reductase EC 1.17.4.2 Vitamin K epoxide reductase Vitamin-K-epoxide reductase (warfarin-sensitive) EC 1.17.4.4 Vitamin-K-epoxide reductase (warfarin-insensitive) EC 1.17.4.5 RRM1 RRM2 RRM2B Category:EC 1.17.5 Caffeine dehydrogenase EC 1.17.5.2 Category:EC 1.17.7 Category:EC 1.17.99
Carrasco had previously been Castillo's Interior Minister during the Bellido cabinet. On 19 November, Presidential Secretary Bruno Pacheco resigned. Pacheco claimed to be innocent, and said he was resigning to stop the smear campaign against the president.
== Early life and education == Philip E. Dawson obtained his bachelor's degree in chemistry from Washington University in St. Louis, graduating magna cum laude. He went on to earn his Ph.D. in chemistry from Scripps Research in 1996. Following his doctoral studies, Dawson conducted postdoctoral research at the California Institute of Technology before returning to Scripps Research as an assistant professor.
=== G protein and β-arrestin pathways === KOR activation initiates both G protein-mediated and β-arrestin-dependent signaling pathways. Following agonist binding, activated Gαi subunits inhibit adenylyl cyclase activity, whilst Gβγ dimers activate G protein-coupled inwardly rectifying potassium channels (GIRKs) and inhibit calcium channels. G protein signaling also initiates early-phase phosphorylation of ERK through Gβγ-mediated activation of phosphoinositide 3-kinase (PI3Ks). After G protein activation, G protein-coupled receptor kinases (GRKs) phosphorylate the receptor, which promotes recruitment of β-arrestins. Their recruitment mediates receptor desensitization, internalization, and downregulation, whilst also initiating distinct signaling cascades independent of G protein activation. β-arrestin2 is the dominant isoform mediating KOR desensitization, β-arrestin1 recruitment to KOR is possible but appears weaker and less functionally significant. β-Arrestin2-mediated signaling includes late-phase ERK phosphorylation and activation of p38 MAPK and c-Jun N-terminal kinase (JNK). Repeated stress produces dynorphin-dependent activation of both KOR and p38 MAPK within GABAergic neurons localized to the nucleus accumbens, prefrontal cortex, and hippocampus. This p38 activation is dependent upon G protein-coupled receptor kinase 3 (GRK3) and β-arrestin2 recruitment and occurs through Ser369 phosphorylation of KOR itself.
Sources: en.wikipedia.org
In the early empirical days of vaccination, before Louis Pasteur's work on establishing the germ theory and Joseph Lister's on antisepsis and asepsis, there was considerable cross-infection. William Woodville, one of the early vaccinators and director of the London Smallpox Hospital is thought to have contaminated the cowpox matter – the vaccine – with smallpox matter and this essentially produced variolation. Other vaccine material was not reliably derived from cowpox, but from other skin eruptions of cattle. During the earlier days of empirical experimentation in 1758, American Calvinist Jonathan Edwards died from a smallpox inoculation. Some of the earliest statistical and epidemiological studies were performed by James Jurin in 1727 and Daniel Bernoulli in 1766. In 1768, Dr John Fewster reported that variolation induced no reaction in persons who had had cowpox.
Traditional dried fruit has a low to moderate glycemic index (GI), a measure of how a food affects blood sugar levels. GI measures an individual's response to eating a carbohydrate-containing food (usually 50 grams of available carbohydrates) compared to the individual's response to the same amount of carbohydrates from either white bread or glucose. Carbohydrate-containing foods are classified as high (above 70), moderate (56–69), or low (0–55) GI. Foods with high fiber content generally have a low GI. However, other factors also contribute to a food's glycemic response, such as the type of carbohydrate or sugar present, the physical characteristics of the food matrix, and the presence of organic acids. All studies assessing the GI of dried fruit show that they are low- to moderate-GI foods and that the insulin response is proportional to their GI. Factors thought to contribute to this glycemic response include the viscous texture of dried fruits when chewed, their whole food matrix, the presence of phenolic compounds and organic acids and the type of sugar present (about 50% fructose in most traditional dried fruit).
A visa is a travel document issued to foreign nationals enabling them to clear border controls. They traditionally take the form of an adhesive sticker or, occasionally, a stamp affixed to a page in an individual's passport or equivalent document. Visas policies different purposes depending on the priorities of each jurisdiction, ranging from ensuring that visitors do not pose a national security risk or have sufficient financial resources to simply functioning as a tax on tourists, as is the case with countries like Mauritius and other leisure destinations which issue visas on arrival, electronic visas, or electronic travel authorisations (ETAs) to most or all visitors. Visas may include limits on the duration of the foreigner's stay, areas within the state they may enter, the dates they may enter, the number of permitted visits, or an individual's right to work in the state in question. Many countries in Asia have liberalised their visa controls in recent years to encourage transnational business and tourism. For example, India, Myanmar, and Sri Lanka have introduced electronic visas to ease border control for business travellers and tourists. Malaysia has introduced similar eVisa facilities and the eNTRI programme to expedite clearance for Indian and mainland Chinese citizens. Thailand regularly issues visas on arrival to many non-exempt visitors at major ports of entry to encourage tourism.
Humans exhibit a variety of abilities. This includes an ability of emotional Hedonic Adaptation, an idea suggesting that beauty, fame and money do not generally have lasting effects on happiness (this effect has also been called the Hedonic treadmill). In this vein, some research has suggested that only recent events, meaning those that occurred within the last 3 months, affect happiness levels. The tendency to adapt, and therefore return to an earlier level of happiness, is illustrated by studies showing lottery winners are no happier in the years after they've won. Other studies have shown paraplegics are nearly as happy as control groups that are not paralyzed, after equally few years. Daniel Kahneman explains: "they are not paraplegic full time... It has to do with allocation of attention". Thus, contrary to our impact biases, lotteries and paraplegia do not change experiences to as great a degree as we would believe. However, in a newer study (2007), winning a medium-sized lottery prize had a lasting mental wellbeing effect of 1.4 GHQ points on Britons even two years after the event. Moreover, adaptation can be a very slow and incomplete process. Distracting life changes such as the death of a spouse or losing one's job can show measurable changes in happiness levels for several years. Even the "adapted" paraplegics mentioned above did ultimately report lower levels of pleasure (again, they were happier than one would expect, but not fully adapted).
Sources: en.wikipedia.org
=== Grigori === Father Grigori (voiced by Jim French) is an Eastern Orthodox Christian priest who appears throughout the Ravenholm chapter of Half-Life 2. He is the only human survivor encountered in Ravenholm. Father Grigori's model is based on video game art director Daniel Dociu. He speaks enthusiastically about "tending to his flock", i.e. dispatching the remaining zombie inhabitants of the city with a Winchester Model 1886 and homemade traps while offering them consolatory words. He helps Gordon Freeman intermittently in Ravenholm, giving him a shotgun, combat tips, and advice mingled with biblical quotations. Eventually, Grigori escorts Freeman through a cemetery infested with zombies to show him a hidden passage to the mines out of the haunted town. After waving Gordon off, Grigori continues fighting the hordes of enemies until he retreats into a nearby tomb, ignites a wall of fire around it and disappears, laughing maniacally. In the Half Life 2: 20th Anniversary documentary it is stated that Doug Woods thought of the idea in a design meeting as a "preacher with a shotgun". Grigori wields a Winchester Model 1886 rifle named Annabelle that can not be used by the player under ordinary circumstances.
The liver is the second largest organ (after the skin) and is an accessory digestive gland which plays a role in the body's metabolism. The liver has many functions some of which are important to digestion. The liver can detoxify various metabolites; synthesise proteins and produce biochemicals needed for digestion. It regulates the storage of glycogen which it can form from glucose (glycogenesis). The liver can also synthesise glucose from certain amino acids. Its digestive functions are largely involved with the breaking down of carbohydrates. It also maintains protein metabolism in its synthesis and degradation. In lipid metabolism it synthesises cholesterol. Fats are also produced in the process of lipogenesis. The liver synthesises the bulk of lipoproteins. The liver is located in the upper right quadrant of the abdomen and below the diaphragm to which it is attached at one part, the bare area of the liver. This is to the right of the stomach and it overlies the gall bladder. The liver synthesises bile acids and lecithin to promote the digestion of fat.
== References == Crowl, Philip A. (1995). The Pacific War: Campaign in the Marianas. United States Army in World War II. United States Army Center of Military History. ISBN 978-0-16-089915-7. LCCN 60-60000. Archived from the original on 21 July 2022. Retrieved 10 February 2017. Hoyt, Edwin Palmer (1986). Japan's War: The Great Pacific Conflict, 1853 to 1952. New York: McGraw-Hill. ISBN 0-07-030612-5. Morison, Samuel Eliot (1953). New Guinea and the Marianas, March 1944 – August 1944. History of United States Naval Operations in World War II. Vol. VIII. Little, Brown and Company. Polmar, Norman (2008). Aircraft Carriers: A History of Carrier Aviation and Its Influence on World Events, 1946–2006. Vol. II. Washington, D.C.: Potomac Books. pp. 377–400. ISBN 978-1-57488-665-8. Archived from the original on 21 July 2022. Retrieved 1 June 2014. Potter, E. B. (1990). Admiral Arleigh Burke. Naval Institute Press. ISBN 978-1-59114-692-6. Roscoe, Theodore (1949). Pig Boats. New York: Bantam Books. ISBN 978-0-553-13040-4. {{cite book}}: ISBN / Date incompatibility (help) Shaw, Henry I. Jr.; Nalty, Bernard C.; Turnbladh, Edwin T. (1966). "Strategic Victory in the Marianas Liberation of Guam; Capture of Saipan and Tinian". Central Pacific Drive (PDF). History of U.S. Marine Corps Operations in World War II. Vol. III. Historical Branch, G-3 Division, Headquarters, U.S. Marine Corps. Archived (PDF) from the original on 26 January 2021. Retrieved 25 November 2020. Shores, Christopher (1985). Duel for the Sky: Ten Crucial Battles of World War II. London: Grub Street. ISBN 978-0-7137-1601-6.
== Structure and properties == Two crystalline forms are known. Orthorhombic β-K2SO4 is the common form, but it converts to α-K2SO4 above 583 °C. These structures are complex, although the sulfate adopts the typical tetrahedral geometry.
In 1941, at age 40, Pauling was diagnosed with Bright's disease, a renal disease. Following the recommendations of Thomas Addis, who actively recruited Ava Helen Pauling as "nutritionist, cook, and eventually as deputy 'doctor'", Pauling believed he was able to control the disease with Addis's then-unusual low-protein salt-free diet and vitamin supplements. Thus Pauling's initial – and intensely personal – exposure to the idea of treating disease with vitamin supplements was positive. In 1965, Pauling read Niacin Therapy in Psychiatry by Abram Hoffer and theorized vitamins might have important biochemical effects unrelated to their prevention of associated deficiency diseases. In 1968, Pauling published a brief paper in Science entitled "Orthomolecular psychiatry", giving a name to the popular but controversial megavitamin therapy movement of the 1970s, and advocating that "orthomolecular therapy, the provision for the individual person of the optimum concentrations of important normal constituents of the brain, may be the preferred treatment for many mentally ill patients." Pauling coined the term "orthomolecular" to refer to the practice of varying the concentration of substances normally present in the body to prevent and treat disease. His ideas formed the basis of orthomolecular medicine, which is not generally practiced by conventional medical professionals and has been strongly criticized. In 1973, with Arthur B.
Sources: en.wikipedia.org
Trial results generally show a small to moderate average improvement in desire scores relative to placebo. The distribution of responses is wide, and some participants show little measurable change. Group averages should not be read as a prediction for any single person.
Nausea, flushing, headache, and transient blood pressure elevation are the most frequently reported events. These typically appear shortly after dosing and are usually described as mild to moderate in severity. Safety data covering long periods of continuous use remain limited.
A short half-life means the compound clears from circulation within hours, so any effect is tied closely to dosing time. Accumulation between doses is therefore unlikely under the studied schedule. The practical consequence is that timing of administration shapes what observers record.
It is a synthetic cyclic peptide that acts as an agonist at melanocortin receptors. It is not a hormone replacement therapy and not a vasodilator in the usual clinical sense, although it does affect vascular tone. Chemically it belongs to the melanocortin analogue family.